Literature DB >> 10188950

Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death.

Y Skoglösa1, A Lewén, N Takei, L Hillered, D Lindholm.   

Abstract

Neurotrophic factors are known to promote neuronal survival during development and after acute brain injury. Recent data suggest that some neuropeptides also exhibit neurotrophic activities, as shown for the pituitary adenylate cyclase activating polypeptide, which increases the survival of various neuronal populations in culture. Employing in situ hybridization techniques, we have studied the regulation of messenger RNA for pituitary adenylate cyclase activating polypeptide and its receptor type 1 after a moderate traumatic brain injury to rat brain cortex. We have further compared their messenger RNA expression to that of brain-derived neurotrophic factor and to the amount of cell death occurring in the brain at various times after the brain injury. Levels of brain-derived neurotrophic factor messenger RNA increased rapidly within 2 h after trauma in cortex and hippocampus, and returned to control levels thereafter. The levels of messenger RNA for pituitary adenylate cyclase activating polypeptide also increased with time in the injured brains and reached maximal expression at 72 h, i.e. the end of the observation period. The alterations in pituitary adenylate cyclase activating polypeptide messenger RNA levels were particularly pronounced in the perifocal region and in the ipsilateral dentate gyrus of the brain injury. In contrast, the messenger RNA levels encoding pituitary adenylate cyclase activating polypeptide receptor type 1 first decreased after trauma and were then normalized in the dentate gyrus. There was a large increase in the number of cells labelled for DNA breaks at 12 h post-trauma, indicative of enhanced cell death. The number of labelled cells, however, decreased at later stages concomitant with an increase in the expression of pituitary adenylate cyclase activating polypeptide messenger RNA. Pituitary adenylate cyclase activating polypeptide rescued cortical neurons in cultures against ionomycin-induced cell death, supporting the concept of a neuroprotective effect for the peptide. These results demonstrate a differential regulation of messenger RNA for brain-derived neurotrophic factor and the pituitary adenylate cyclase activating polypeptide and its receptor after brain trauma. The data also suggest that pituitary adenylate cyclase activating polypeptide might have a beneficial effect in brain injury by counteracting neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188950     DOI: 10.1016/s0306-4522(98)00414-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

2.  PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity.

Authors:  Kazuyuki Miyamoto; Tomomi Tsumuraya; Hirokazu Ohtaki; Kenji Dohi; Kazue Satoh; Zhifang Xu; Sachiko Tanaka; Norimitsu Murai; Jun Watanabe; Koichi Sugiyama; Tohru Aruga; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2014-06-08       Impact factor: 3.444

3.  NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways.

Authors:  E A Mercer; L Korhonen; Y Skoglösa; P A Olsson; J P Kukkonen; D Lindholm
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

4.  Energy metabolic changes in the early post-injury period following traumatic brain injury in rats.

Authors:  Niklas Marklund; Konstantin Salci; Gunnar Ronquist; Lars Hillered
Journal:  Neurochem Res       Date:  2006-08-15       Impact factor: 3.996

5.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

6.  Developmental traumatic brain injury decreased brain derived neurotrophic factor expression late after injury.

Authors:  Michelle Elena Schober; Benjamin Block; Daniela F Requena; Merica A Hale; Robert H Lane
Journal:  Metab Brain Dis       Date:  2012-04-25       Impact factor: 3.584

7.  Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury.

Authors:  Daisuke Tsuchikawa; Tomoya Nakamachi; Masashi Tsuchida; Yoshihiro Wada; Motohide Hori; Jozsef Farkas; Akira Yoshikawa; Nobuyuki Kagami; Nori Imai; Norihito Shintani; Hitoshi Hashimoto; Takashi Atsumi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-07       Impact factor: 3.444

8.  Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact.

Authors:  Camila P Almeida-Suhett; Zheng Li; Ann M Marini; Maria F M Braga; Lee E Eiden
Journal:  J Neurotrauma       Date:  2014-03-03       Impact factor: 5.269

9.  Effect of controlled cortical impact on the passage of pituitary adenylate cyclase activating polypeptide (PACAP) across the blood-brain barrier.

Authors:  Elizabeth M Rhea; Kristin M Bullock; William A Banks
Journal:  Peptides       Date:  2017-10-28       Impact factor: 3.750

Review 10.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.